Results
1 -
4 of
4Pharmacological analysis of wild-type ??, ?? and ?? subtypes of the human peroxisome proliferator-activated receptor, Naunyn-Schmiedeberg's Archives of Pharmacology Rational drug design and PPAR Agonists, Current Diabetes Reports A Dual PPAR ??/?? Agonist Increases Adiponectin and Improves Plasma Lipid Profiles in Healthy Subjects, Drugs in R&D